STELARA®
(ustekinumab)
Medical inquiries
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
STELARA® (ustekinumab)
Medical Information
STELARA and Adalimumab in Crohn’s Disease - SEAVUE Study
Last Updated: 01/21/2025
Summary
A summary of this response is provided as an interactive PDF (iPDF) that can be accessed by clicking the following link:
- STELARA®
(ustekinumab) - STELARA and Adalimumab in Crohn’s Disease - SEAVUE Study - Minimum requirement to access interactive content: Adobe Acrobat Reader
- The executive summary infographic of the iPDF content is provided below
